Alyeska Investment Group’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-225,000
| Closed | -$297K | – | 622 |
|
|
2023
Q1 | $297K | Hold |
225,000
| – | – | ﹤0.01% | 403 |
|
|
2022
Q4 | $380K | Hold |
225,000
| – | – | ﹤0.01% | 381 |
|
|
2022
Q3 | $416K | Hold |
225,000
| – | – | ﹤0.01% | 358 |
|
|
2022
Q2 | $691K | Hold |
225,000
| – | – | 0.01% | 514 |
|
|
2022
Q1 | $1.63M | Hold |
225,000
| – | – | 0.02% | 453 |
|
|
2021
Q4 | $3.68M | Sell |
225,000
-225,000
| -50% | -$3.68M | 0.04% | 333 |
|
|
2021
Q3 | $4.48M | Hold |
450,000
| – | – | 0.06% | 354 |
|
|
2021
Q2 | $4.49M | Hold |
450,000
| – | – | 0.05% | 371 |
|
|
2021
Q1 | $4.48M | Buy |
+450,000
| New | +$4.48M | 0.06% | 338 |
|